- Home
- CVLT vs ALKS Comparison
CVLT vs ALKS Comparison
Compare CVLT & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVLT | ALKS |
|---|---|---|
| Founded | 1996 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.5B |
| IPO Year | 2006 | 2012 |
Fundamental Metrics
Financial Performance| Metric | CVLT | ALKS |
|---|---|---|
| Price | $96.13 | $34.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 14 |
| Target Price | ★ $142.00 | $43.43 |
| AVG Volume (30 Days) | 1.1M | ★ 2.7M |
| Earning Date | 04-28-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.24 | ★ 1.43 |
| Revenue | $995,619,000.00 | ★ $1,475,899,000.00 |
| Revenue This Year | $20.73 | $24.26 |
| Revenue Next Year | $11.56 | $4.47 |
| P/E Ratio | $75.97 | ★ $24.16 |
| Revenue Growth | ★ 18.63 | N/A |
| 52 Week Low | $71.75 | $25.17 |
| 52 Week High | $200.68 | $36.48 |
Technical Indicators
Market Signals| Indicator | CVLT | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 71.67 | 58.99 |
| Support Level | $80.85 | $26.80 |
| Resistance Level | $129.23 | $35.47 |
| Average True Range (ATR) | 4.90 | 1.36 |
| MACD | 2.17 | 0.06 |
| Stochastic Oscillator | 94.95 | 42.89 |
Price Performance
Historical ComparisonAbout CVLT Commvault Systems Inc.
CommVault Systems Inc provides data and information management software applications and services. The firm sells software licenses and services to large global enterprises, small- and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Its software solutions include Cleanroom Recovery, HyperScale X, Air Gap Protect, Compliance, Cloud Rewind, and Clumio Backtrack. The company operates in the United States and exports to many other countries.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.